{
  "ptid_time": "099_S_0054_2005-11-16",
  "img_path": "/data/qiuhui/data/adni/images/099_S_0054/2005-11-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 69,287 mm³, 87.4% above the reference mean. With a Z-score of 2.36 (99.1th percentile), this represents significant enlargement; hippocampal volume measures 4,845 mm³, 25.4% below the reference mean. With a Z-score of -2.04 (2.1th percentile), this represents significant atrophy; whole brain volume measures 833,179 mm³, 10.2% below the reference mean. With a Z-score of -1.23 (11.0th percentile), this represents mild atrophy; entorhinal cortex volume measures 1,608 mm³, 53.6% below the reference mean. With a Z-score of -2.89 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 13,023 mm³, 19.2% below the reference mean. With a Z-score of -1.44 (7.5th percentile), this represents mild atrophy; middle temporal gyrus volume measures 14,532 mm³, 19.4% below the reference mean. With a Z-score of -1.73 (4.2th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 81.0 years. Gender is Female. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Major Surgical Procedures. MMSE: 27.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex) and moderate-to-severe ventricular enlargement, consistent with neurodegeneration. However, the MMSE score of 27 is within the normal range (≥26), and the absence of APOE4 reduces genetic risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (High structural evidence of atrophy but conflicting clinical/cognitive findings).  \n\n*Note: Progression to dementia is likely if atrophy progresses or cognitive scores decline. Follow-up clinical and neuropsychological assessments are recommended.*",
  "timestamp": "2025-07-26T10:51:33.323027"
}